RxDoctor Payments Data

Anna McFarland

Pediatrics · Lansing, MINPI 1942795463

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $479 and has fallen 65.5% since, to $166 in 2025. Among pediatrics clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,596in general payments, 2019–2025

Across 77 payments — averaging $20.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$243
  • Merck$159
  • Pfizer$151
  • Seqirus USA Inc$121
  • Phadia US Inc.$121
  • Sobi, Inc$101
  • plus $701 from 19 others

What the payments were for

  • Food & beverage$1,590100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,596 in reported general payments places this provider in the 90th percentile of 1,473 pediatrics providers in Michigan.

See all pediatrics providers in Michigan →

Other pediatrics in Lansing

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →